MEDP: Medpace Holdings, Inc. - Summary | Jitta

Medpace Holdings, Inc.

NASDAQ:MEDP

Price
$174.69
Loss Chance
39.4%
7.30JITTA SCORE
263.78%Over Jitta Line
Jitta Ranking
52 / 1,042
916 / 4,597
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (72)
Recent Business Performance (86)
Financial Strength (87)
Return to Shareholders (40)
Competitive Advantage (76)
Jitta Signs
Revenue and EarningConsistent High Growth in the past 5 years
Recent Business PerformanceEarning Growth Last Year
Debt LevelLow Long Term Debt
Share RepurchaseEvery Year
SG&A to SalesDecreasing
Cash Conversion CycleLess than 60 days
Key Stats
Jitta Score
Jitta Line
7.30
263.78%
2.24
353.92%
Life Sciences Tools and Services
7.15
148.21%
5.51
12.63%
6.99
142.42%
COMPANY DESCRIPTION
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It also provides clinical development services to the biotechnology, pharmaceutical, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. The company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.